Development Agreements in the Pharmaceuticals Industry

317 Contracts & Agreements
Browse by Company
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
LibiGel once daily transdermal testosterone gel in Phase III development for treatment of female sexual dysfunction (FSD)
Development Agreements
ANI Pharma Inc
Pharmaceuticals
DE
2008
Amendment of Solicitation/Modification of Contract 00016, dated July 18, 2024, to Agreement, dated September 10, 2018, by and between SIGA and the Biomedical Advanced Research and...
Development Agreements
SIGA TECHNOLOGIES INC
Pharmaceuticals
2024
Amendment of Solicitation/Modification of Contract 00015, dated February 9, 2024, to Agreement, dated September 10, 2018, by and between SIGA and the Biomedical Advanced Research...
Development Agreements
SIGA TECHNOLOGIES INC
Pharmaceuticals
2024
Amendment of Solicitation/Modification of Contract 00014, dated October 18, 2023, to Agreement, dated September 10, 2018, by and between SIGA and the Biomedical Advanced Research...
Development Agreements
SIGA TECHNOLOGIES INC
Pharmaceuticals
2024
Third Amendment to Development and Commercialization Agreement, dated January 6, 2024, by and between the Company, Pulmatrix Operating Company, Inc., and Cipla Technologies LLC
Development Agreements
Pulmatrix, Inc.
Pharmaceuticals
2024
Amendment of Solicitation/Modification of Contract 000024, dated September 21, 2023, to Agreement, dated June 1, 2011, by and between SIGA and the Biomedical Advanced Research and...
Development Agreements
SIGA TECHNOLOGIES INC
Pharmaceuticals
2023
Amendment of Solicitation/Modification of Contract 00013, dated July 27, 2023, to Agreement, dated September 10, 2018, by and between SIGA and the Biomedical Advanced Research and...
Development Agreements
SIGA TECHNOLOGIES INC
Pharmaceuticals
2023
Technology Transfer Contract, dated November 28, 2022, between Hainan Helpson Medical & Biotechnology Co., Ltd and Chengdu Bonier Medical Technology Development Co., Ltd
Development Agreements
CHINA PHARMA HOLDINGS, INC.
Pharmaceuticals
2022
Development and Manufacturing Services Agreement, dated November
Development Agreements
Context Therapeutics Inc.
Pharmaceuticals
NY
2022
Amendment No. 3 to Process Development Agreement
Development Agreements
Context Therapeutics Inc.
Pharmaceuticals
2022
Amendment of Solicitation/Modification of Contract 000022, dated September 29, 2022, to Agreement, dated May 13, 2011, by and between SIGA and the Biomedical Advanced Research and...
Development Agreements
SIGA TECHNOLOGIES INC
Pharmaceuticals
2022
Amendment of Solicitation/Modification of Contract 000021, dated September 28, 2022, to Agreement, dated May 13, 2011, by and between SIGA and the Biomedical Advanced Research and...
Development Agreements
SIGA TECHNOLOGIES INC
Pharmaceuticals
2022
Amendment of Solicitation/Modification of Contract 000012, dated August 5, 2022, to Agreement, dated September 10, 2018, by and between SIGA and the Biomedical Advanced Research...
Development Agreements
SIGA TECHNOLOGIES INC
Pharmaceuticals
2022
Amendment of Solicitation/Modification of Contract 000011, dated July 26, 2022, to Agreement, dated September 10, 2018, by and between SIGA and the Biomedical Advanced Research...
Development Agreements
SIGA TECHNOLOGIES INC
Pharmaceuticals
2022
Amendment of Solicitation/Modification of Contract 00010, dated March 29, 2022, to Agreement, dated September 10, 2018, by and between SIGA and the Biomedical Advanced Research...
Development Agreements
SIGA TECHNOLOGIES INC
Pharmaceuticals
2022
Amendment of Solicitation/Modification of Contract 00009, dated January 27, 2022, to Agreement, dated September 10, 2018, by and between SIGA and the Biomedical Advanced Research...
Development Agreements
SIGA TECHNOLOGIES INC
Pharmaceuticals
2022
Amendment No. 2, dated September 21, 2022, by and between Marinus Pharmaceuticals, Inc. and the Biomedical Advanced Research and Development Authority, a division of the U.S....
Development Agreements
MARINUS PHARMACEUTICALS INC
Pharmaceuticals
2022
Amendment of Solicitation/Modification of Contract 000023, dated February 15, 2022, to Agreement, dated June 1, 2011, by and between SIGA and the Biomedical Advanced Research and...
Development Agreements
SIGA TECHNOLOGIES INC
Pharmaceuticals
2022
American Development Partners development agreement
Development Agreements
Canbiola, Inc.
Pharmaceuticals
TN
2022
Amendment, dated March 29, 2022, by and between Marinus Pharmaceuticals, Inc. and the Biomedical Advanced Research and Development Authority, a division of the U.S. Department of...
Development Agreements
MARINUS PHARMACEUTICALS INC
Pharmaceuticals
2022
Amendment Agreement by and between Verona Pharma plc and Ligand UK Development Limited dated March 24, 2022
Development Agreements
Verona Pharma plc
Pharmaceuticals
2022
Amendment of Solicitation/Modification of Contract 00022, dated November 8, 2021, to Agreement, dated June 1, 2011, by and between SIGA and the Biomedical Advanced Research and...
Development Agreements
SIGA TECHNOLOGIES INC
Pharmaceuticals
2022
Amendment of Solicitation/Modification of Contract 00020, dated November 8, 2021, to Agreement, dated May 13, 2011, by and between SIGA and the Biomedical Advanced Research and...
Development Agreements
SIGA TECHNOLOGIES INC
Pharmaceuticals
2022
Amendment of Solicitation/Modification of Contract 00008, dated December 9, 2021, to Agreement, dated September 10, 2018, by and between SIGA and the Biomedical Advanced Research...
Development Agreements
SIGA TECHNOLOGIES INC
Pharmaceuticals
2022
Amendment of Solicitation/Modification of Contract 00006, dated April 29, 2021, to Agreement, dated September 10, 2018, by and between SIGA and the Biomedical Advanced Research...
Development Agreements
SIGA TECHNOLOGIES INC
Pharmaceuticals
2022
Development Funding and Royalties Agreement, dated May 4, 2019, by and between Novan, Inc. and Ligand Pharmaceuticals Incorporated
Development Agreements
Novan, Inc.
Pharmaceuticals
NY
2022
Research, Development and Supply Agreement, dated as of December 9, 2019, and Deed of Amendment, dated as of July 26, 2021, by and between the Registrant and ICE S.p.A. (formerly...
Development Agreements
Amylyx Pharmaceuticals, Inc.
Pharmaceuticals
2021
Development Financing Agreement, dated July 30, 2021, by and between CymaBay Therapeutics, Inc. and ABW Cyclops SPV LP
Development Agreements
CymaBay Therapeutics, Inc.
Pharmaceuticals
NY
2021
Second Amendment to Development and Commercialization Agreement
Development Agreements
Pulmatrix, Inc.
Pharmaceuticals
2021
Modification of Contract No. 3, dated September 23, 2021, between Paratek Pharmaceuticals, Inc. and the Biomedical Advanced Research and Development Authority of the United States...
Development Agreements
Paratek Pharmaceuticals, Inc.
Pharmaceuticals
2021
Modification of Contract No. 2, dated July 29, 2021, between Paratek Pharmaceuticals, Inc. and the Biomedical Advanced Research and Development Authority of the United States...
Development Agreements
Paratek Pharmaceuticals, Inc.
Pharmaceuticals
2021
Amendment of Solicitation/Modification of Contract 0007, dated September 8, 2021, to Agreement, dated September 10, 2018, by and between SIGA and the Biomedical Advanced Research...
Development Agreements
SIGA TECHNOLOGIES INC
Pharmaceuticals
2021
Agreement for Rendering of Research Services between Virpax Pharmaceuticals, Inc. and Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd., dated June...
Development Agreements
Virpax Pharmaceuticals, Inc.
Pharmaceuticals
2021
Amendment No. 2 to Process Development Agreement, dated June 3, 2021, between Context Therapeutics LLC and Tyligand Bioscience (Shanghai) Limited
Development Agreements
Context Therapeutics Inc.
Pharmaceuticals
2021
Amendment No. 1 to Process Development Agreement, dated April 21, 2021, between Context Therapeutics LLC and Tyligand Bioscience (Shanghai) Limited
Development Agreements
Context Therapeutics Inc.
Pharmaceuticals
2021
Process Development Agreement, dated March 6, 2020, between Context Therapeutics LLC and Tyligand Bioscience (Shanghai) Limited
Development Agreements
Context Therapeutics Inc.
Pharmaceuticals
NY
2021
Corporate Advisory Agreement (Research & Development) between the Company and GYB, LLC dated May 18, 2021
Development Agreements
MJ Holdings, Inc.
Pharmaceuticals
2021
Strategic Development Agreement dated March 14, 2021
Development Agreements
IntelGenx Technologies Corp.
Pharmaceuticals
NY
2021
Development and Commercialization Agreement by and between Theravance Biopharma R&D, Inc. and Mylan Ireland Limited, dated January 30, 2015
Development Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
NY
2021
Agreement for the Rendering of Research Services by and between Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd. and Virpax Pharmaceuticals, Inc.,...
Development Agreements
Virpax Pharmaceuticals, Inc.
Pharmaceuticals
2020
Agreement for the Rendering of Research Services by and between Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd. and Virpax Pharmaceuticals, Inc.,...
Development Agreements
Virpax Pharmaceuticals, Inc.
Pharmaceuticals
2020